These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population. Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681 [TBL] [Abstract][Full Text] [Related]
24. Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020. Lin X; Qin X; Wu X; Liao Y; Yu Y; Xie Q; Tang S; Guo C; Pei J; Wu Z; Cai C; Wang F; Wu S; Chen H; Liu X; Li M; Cao W; Zheng H Antimicrob Agents Chemother; 2022 Apr; 66(4):e0229421. PubMed ID: 35345891 [TBL] [Abstract][Full Text] [Related]
25. Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731 [TBL] [Abstract][Full Text] [Related]
26. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA. Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088 [TBL] [Abstract][Full Text] [Related]
27. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957 [TBL] [Abstract][Full Text] [Related]
28. WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014. Jacobsson S; Golparian D; Cole M; Spiteri G; Martin I; Bergheim T; Borrego MJ; Crowley B; Crucitti T; Van Dam AP; Hoffmann S; Jeverica S; Kohl P; Mlynarczyk-Bonikowska B; Pakarna G; Stary A; Stefanelli P; Pavlik P; Tzelepi E; Abad R; Harris SR; Unemo M J Antimicrob Chemother; 2016 Nov; 71(11):3109-3116. PubMed ID: 27432597 [TBL] [Abstract][Full Text] [Related]
29. Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Shimuta K; Unemo M; Nakayama S; Morita-Ishihara T; Dorin M; Kawahata T; Ohnishi M; Antimicrob Agents Chemother; 2013 Nov; 57(11):5225-32. PubMed ID: 23939890 [TBL] [Abstract][Full Text] [Related]
30. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013. Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P; Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan. Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234 [TBL] [Abstract][Full Text] [Related]
32. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
33. Antimicrobial susceptibilities and molecular typing of neisseria gonorrhoeae isolates at a medical centre in Taiwan, 2001-2013 with an emphasis on high rate of azithromycin resistance among the isolates. Liu YH; Huang YT; Liao CH; Hsueh PR Int J Antimicrob Agents; 2018 May; 51(5):768-774. PubMed ID: 29477549 [TBL] [Abstract][Full Text] [Related]
34. Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16. Golparian D; Bazzo ML; Ahlstrand J; Schörner MA; Gaspar PC; de Melo Machado H; Martins JM; Bigolin A; Ramos MC; Ferreira WA; Pereira GFM; Miranda AE; Unemo M; J Antimicrob Chemother; 2024 May; 79(5):1081-1092. PubMed ID: 38517452 [TBL] [Abstract][Full Text] [Related]
35. NG-STAR genotypes are associated with MDR in Neisseria gonorrhoeae isolates collected in 2017 in Shanghai. Yang Y; Yang Y; Martin I; Dong Y; Diao N; Wang Y; Demczuk W; Gu W J Antimicrob Chemother; 2020 Mar; 75(3):566-570. PubMed ID: 31713620 [TBL] [Abstract][Full Text] [Related]
36. Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012. Kubanova A; Kubanov A; Frigo N; Solomka V; Semina V; Vorobyev D; Khairullin R; Unemo M BMC Infect Dis; 2014 Jun; 14():342. PubMed ID: 24947981 [TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. Olsen B; Pham TL; Golparian D; Johansson E; Tran HK; Unemo M BMC Infect Dis; 2013 Jan; 13():40. PubMed ID: 23351067 [TBL] [Abstract][Full Text] [Related]
38. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019. Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450 [TBL] [Abstract][Full Text] [Related]